Le Lézard
Classified in: Health
Subject: AWD

2e CEO, Ross Toohey, Wins Silver MM&M Agency Entrepreneur Of The Year

ST. LOUIS, Oct. 12, 2019 /PRNewswire/ -- 2e, an internationally recognized healthcare marketing strategy firm focused on launching pharmaceutical and medical device products, is celebrating a silver win for their CEO, Ross Toohey, at last night's MM&M Awards in New York City.

2e Team celebrates CEO, Ross Toohey's Agency Entrepreneur of the Year Silver win at the 2019 MM&M Awards.

A panel of 70 judges reviewed over 700 entries before selecting the award recipients. 2e were finalists for "Digital Initiative for Non-Consumers" and "Use of Payer Marketing" for Novartis, as well as "Corporate Branding Campaign" for the TLC "Only TLC Sees You" campaign. The agency also sponsored the Young Marketer award and were proud to see silver presented to their client, Nishant Maller, from Alcon.

Toohey said, "It's an honor to have won silver for Agency Entrepreneur of the Year. But the real win is getting to work with my fellow 2e-ers and amazing clients, like Nishant, who have the courage to push the boundaries as well as the commitment to improve outcomes for patients, surgeons and healthcare professionals."

2019 has been a thrilling year for 2e. In June, it celebrated its 20th Anniversary. In August, hot on the heels of the agency's appointment to the MM&M Top 100 Healthcare Agencies Worldwide, they announced their partnership with Fishawack, the largest global healthcare communications group. If that wasn't enough, they're also an MM&M record-breaker, winning "Healthcare Agency of the Year" for three consecutive years (2015, 2016, and 2017).

"Every day we wake up to connect more people to the therapies and technologies that will shape a better future for everyone. We may have entered our 20th year, but we're just getting started," says Toohey.

For more information about the other 2019 MM&M Awards and a listing of this year's winners, visit: https://www.mmm-online.com/mmm-awards/2019-mmm-awards-all-the-winners/

About 2e

2e is the launch and growth agency behind the people and advancements that expand possibilities for human health. After three consecutive MM&M Healthcare Agency of the Year victories, 2e has set its sights on redefining the way pharmaceutical, medical device, and life science brands are introduced to and shared with the world. Partnering with clients who share this aspiration, 2e is connecting more people with the therapies and technologies that will shape a better future. With offices across the Midwest and California, the agency's 150-plus employees are advancing industry expectations for branding, marketing strategy, digital engagement, sales training, and more.

About the Fishawack Group

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in the UK (Manchester, Oxford, London, and Brighton), the USA (Philadelphia, PA, New York, NY, and San Diego, CA), Switzerland (Basel), and India (Hyderabad).

Fishawack comprises two international divisions, Fishawack Medical Communications, developing and delivering services in the fields of medical communications, scientific engagement, publications, market access, strategic consultancy, and thought leader consultancy, and Fishawack Creative, offering strategic planning, creative development, advertising and promotion, and tactical execution.

We have built our reputation on excellence, creativity, and transparency.

Media Contact:
Jessica Boden

(PRNewsfoto/2e Group)

SOURCE 2e Creative

These press releases may also interest you

at 01:00
A large portion of the population ? as...

at 01:00
The marketing of alcoholic beverages is one cause of underage drinking, according to new research in the Journal of Studies on Alcohol and Drugs. Because of this, countries should abandon what are often piecemeal and voluntary codes to restrict...

at 00:14
Nanalysis Scientific Corp. (Nanalysis, TSXV:NSCI, FRA:1N1) is pleased to announce that it has entered into a contract to acquire 100 percent of RS2D S.A.S. (RS2D), a global leader in next-gen electronics for MRI and NMR systems. Closing of the...

at 00:05
Invetx, a pioneering animal health biopharmaceutical company, today announced a $15 million Series A financing and founding collaborations with WuXi Biologics and AbCellera. The financing was led by Invetx's founding investor, Anterra Capital, and...

at 00:01
For a sixth year, Heart & Stroke is urging Quebecers to learn the signs of stroke and what to do when they see them, with the help of the FAST campaign, featuring Josée Boudreault and Louis-Philippe Rivard. Knowing the signs can make the difference...

23 fév 2020
Further to my previous statements, as Chief Public Health Officer, I have assessed individuals in quarantine at the NAV CENTRE pursuant to an Emergency Order under the Quarantine Act and determined that they do not pose a risk of significant harm to...

News published on 12 october 2019 at 16:03 and distributed by: